Kris Vinckier

Tom's of Maine, Inc. manufactures and markets personal care products. It provides natural products for hair, teeth, skin and cold care. It also manufactures antiperspirants, soaps, shampoos and shaving cream made from natural ingredients. The company was founded in 1970 by Tom Chappell and Kate Chappell and is headquartered in Kennebunk, ME.

BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.

The American Academy of Pediatric Dentistry operates a pediatric dental clinic. The non-profit company is based in Chicago, IL.

The Forsyth Institute is a non-profit research organization founded in 1910, located in Cambridge, MA. The private company is dedicated to understanding the connections between oral health and overall wellness. Forsyth scientists have identified and characterized many of the oral bacteria that play a role in oral diseases and increase the risk of other diseases in the body. The company is committed to treating underserved populations in local communities and on a national scale. Forsyth has been a leader in oral health research and pediatric dental care for over 100 years. The CEO of the company is Wenyuan Shi.

Azure Biotech, Inc. is a private biotechnology company that is developing an alternative product to address the many drawbacks of current therapies for vulvovaginal atrophy (VVA). The company is based in New York, NY. The company has the exclusive worldwide rights to all topical formulations of lasofoxifene, a selective estrogen receptor modulator (SERM). Azure plans to rapidly build upon the extensive safety and efficacy data already available from clinical trials previously completed with an oral formulation in more than 15,000 women. The company was founded by David Thompson.